New Drug News

27 Aug 20265:59 am

Science27 Aug 2026 · 5:59 am5:59 am

FDA Approves Daraxonrasib, New Pancreatic Cancer Drug Showing Extended Survival

The FDA has approved daraxonrasib, a new pancreatic cancer drug that extended patients' lives to a median of 13.2 months compared to 6.7 months with chemotherap

18 Jul 20267:16 am

Health18 Jul 2026 · 7:16 am7:16 am

Create visual

FDA Approves Merck's New Once-Daily Cholesterol Pill, Lipfendra

The FDA has approved Merck's new once-daily cholesterol pill, Lipfendra (enlicitide), marking it as the first oral PCSK9 inhibitor available. This approval intr

New Drug News

#New Drug

FDA Approves Daraxonrasib, New Pancreatic Cancer Drug Showing Extended Survival

FDA Approves Merck's New Once-Daily Cholesterol Pill, Lipfendra

Discover Faster

Stay Organized

Create Effortlessly

Drive Greater Impact

Newsroom FAQs